Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Synopsis This study investigates the impact of excessive glutathione intake on breast cancer chemotherapy resistance, showing that higher intake is linked to increased recurrence rates and poor prognosis, emphasizing the need for standardized glutathione usage during treatment
These genetic predispositions may help provide context for how your body metabolizes GLP-1 therapies and manages antioxidant burden
Jiang's team to customize your IV therapy plan
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
Biochemical Pharmacology, 181 114096, 114096
US$ 24.65
US$ 29.32
US$ 22.45
US$ 29.19
US$ 21.51
US$ 28.44
.webp)
US$ 21.54
.webp)
US$ 24.35
US$ 23.68
